share_log

BTIG Maintains Buy on Globus Medical, Raises Price Target to $63

Benzinga ·  May 8 12:38

BTIG analyst Ryan Zimmerman maintains Globus Medical (NYSE:GMED) with a Buy and raises the price target from $60 to $63.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment